Skip to main content
Top
Published in: Archives of Virology 7/2009

01-07-2009 | Original Article

Analysis of vaccine-virus-associated rabies cases in red foxes (Vulpes vulpes) after oral rabies vaccination campaigns in Germany and Austria

Authors: Thomas Müller, H.-J. Bätza, A. Beckert, C. Bunzenthal, J. H. Cox, C. M. Freuling, A. R. Fooks, J. Frost, L. Geue, A. Hoeflechner, D. Marston, A. Neubert, L. Neubert, S. Revilla-Fernández, E. Vanek, A. Vos, E. Wodak, K. Zimmer, T. C. Mettenleiter

Published in: Archives of Virology | Issue 7/2009

Login to get access

Abstract

To eradicate rabies in foxes, almost 97 million oral rabies vaccine baits have been distributed in Germany and Austria since 1983 and 1986, respectively. Since 2007, no terrestrial cases have been reported in either country. The most widely used oral rabies vaccine viruses in these countries were SAD (Street Alabama Dufferin) strains, e.g. SAD B19 (53.2%) and SAD P5/88 (44.5%). In this paper, we describe six possible vaccine-virus-associated rabies cases in red foxes (Vulpes vulpes) detected during post-vaccination surveillance from 2001 to 2006, involving two different vaccines and different batches. Compared to prototypic vaccine strains, full-genome sequencing revealed between 1 and 5 single nucleotide alterations in the L gene in 5 of 6 SAD isolates, resulting in up to two amino acid substitutions. However, experimental infection of juvenile foxes showed that those mutations had no influence on pathogenicity. The cases described here, coming from geographically widely separated regions, do not represent a spatial cluster. More importantly, enhanced surveillance showed that the vaccine viruses involved did not become established in the red fox population. It seems that the number of reported vaccine virus-associated rabies cases is determined predominantly by the intensity of surveillance after the oral rabies vaccination campaign and not by the selection of strains.

Footnotes
1

At that time, Germany was still divided into two countries: the German Democratic Republic and the Federal Republic of Germany. To prevent confusion, all figures on rabies cases and the number of vaccine baits distributed in these countries prior to reunification are combined in a single figure representing Germany.

 
Literature
  1. Artois M, Aubert MFA (1985) Behaviour of rabid foxes. Rev Ecol 40:172–176
  2. Artois M, Cliquet F, Barrat J, Schumacher CL (1997) Effectiveness of SAG1 oral vaccine for the long-term protection of red foxes (Vulpes vulpes) against rabies. Vet Rec 140:57–59PubMed
  3. Beckert A, Geue L, Vos A, Neubert A, Freuling C, Muller T (2009) Genetic stability (in vivo) of the attenuated oral rabies virus vaccine SAD B19. Microbiol Immunol 53:16–21PubMedView Article
  4. Blancou J, Andrak B, Andral L (1980) A model in mice for the study of the early death phenomenon after vaccination and challenge with rabies virus. J Gen Virol 50:433–435PubMedView Article
  5. Blancou J, Meslin FX (1996) Modified live-virus rabies vaccines for oral immunization of carnivores. In: Meslin FX, Kaplan MM, Koprowski H (eds) Laboratory techniques in rabies, 4th edn. World Health Organization, Geneva, pp 324–337
  6. Brochier BM, Blancou J, Aubert MFA, Kieny MP, Desmettre P, Pastoret PP (1989) Interaction between rabies infection and oral administration of vaccinia-rabies recombinant virus to foxes (Vulpes vulpes). J Gen Virol 70:1601–1604PubMedView Article
  7. Bush M, Montali RJ, Brownstein D, James AE Jr, Appel MJ (1976) Vaccine-induced canine distemper in a lesser panda. J Am Vet Med Assoc 169:959–960PubMed
  8. Carpenter JW, Appel MJ, Erickson RC, Novilla MN (1976) Fatal vaccine-induced canine distemper virus infection in black-footed ferrets. J Am Vet Med Assoc 169:961–964PubMed
  9. Cherkasova EA, Korotkova EA, Yakovenko ML, Ivanova OE, Eremeeva TP, Chumakov KM, Agol VI (2002) Long-term circulation of vaccine-derived poliovirus that causes paralytic disease. J Virol 76:6791–6799PubMedView Article
  10. Chipman R, Slate D, Rupprecht C, Mendoza M (2008) Downside risk of wildlife translocation. Dev Biol (Basel 131:223–232
  11. Ciuchini F, Bozzano AI, Pestalozza S, Tollis M (1988) Research on susceptibility of cats to the oral administration of rabies vaccine SAD B19 Tü. J Vet Med B 35:677–680
  12. Conzelmann KK, Cox JH, Schneider LG, Thiel HJ (1990) Molecular cloning and complete sequence of the attenuated rabies virus SAD B19. Virology 175:485–499PubMedView Article
  13. Cox JH, Schneider LG (1976) Prophylactic immunization of humans against rabies by intradermal inoculation of human diploid cell culture vaccine. J Clin Microbiol 3:96–101PubMed
  14. Cox JH, Schneider LG, Muller WW (1992) An antigenic variant of fox rabies virus in Europe. Tierarztl Umschau 47:824–828
  15. Dean DJ, Abelseth MK, Athanasiu P (1996) The fluorescence antibody test. In: Meslin FX, Kaplan MM, Koprowski H (eds) Laboratory techniques in rabies, 4th edn. World Health Organization, Geneva, pp 88–93
  16. Dietzschold B, Wunner WH, Wiktor TJ, Lopes AD, Lafon M, Smith CL, Koprowski H (1983) Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci USA 80:70–74PubMedView Article
  17. Driesel G, Diedrich S, Kunkel U, Schreier E (1995) Vaccine-associated cases of poliomyelitis over a 30 year period in East Germany. Eur J Epidemiol 11:647–654PubMedView Article
  18. Durchfeld B, Baumgartner W, Herbst W, Brahm R (1990) Vaccine-associated canine distemper infection in a litter of African hunting dogs (Lycaon pictus). J Vet Med B 37:203–212
  19. East ML, Hofer H, Cox JH, Wulle U, Wiik H, Pitra C (2001) Regular exposure to rabies virus and lack of symptomatic disease in Serengeti spotted hyenas. Proc Natl Acad Sci USA 98:15026–15031PubMedView Article
  20. European Commission (2002) The oral vaccination of foxes against rabies. European Commission, Brussels
  21. Faber M, Faber ML, Papaneri A, Bette M, Weihe E, Dietzschold B, Schnell MJ (2005) A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity. J Virol 79:14141–14148PubMedView Article
  22. Fehlner-Gardiner C, Nadin-Davis S, Armstrong J, Muldoon F, Bachmann P, Wandeler A (2008) ERA vaccine-derived cases of rabies in wildlife and domestic animals in Ontario, Canada, 1989–2004. J Wildl Dis 44:74–85
  23. Fenje P (1960) Propagation of rabies virus in cultures of hamster kidney cells. Can J Microbiol 6:479–484PubMedView Article
  24. Frolich K, Czupalla O, Haas L, Hentschke J, Dedek J, Fickel J (2000) Epizootiological investigations of canine distemper virus in free-ranging carnivores in Germany. Vet Microbiol 74:283–292PubMedView Article
  25. Georgescu MM, Balanant J, Macadam A, Otelea D, Combiescu M, Combiescu AA, Crainic R, Delpeyroux F (1997) Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis. J Virol 71:7758–7768PubMed
  26. Geue L, Schares S, Schnick C, Kliemt J, Beckert A, Freuling C, Conraths FJ, Hoffmann B, Zanoni R, Marston D, McElhinney L, Johnson N, Fooks AR, Tordo N, Müller T (2008) Genetic characterisation of attenuated SAD rabies virus strains used for oral vaccination of wildlife. Vaccine 26:3227–3235PubMedView Article
  27. Heaton PR, Johnstone P, McElhinney LM, Cowley R, O’Sullivan E, Whitby JE (1997) Heminested PCR assay for detection of six genotypes of rabies and rabies-related viruses. J Clin Microbiol 35:2762–2766PubMed
  28. Johnson N, Dicker A, Mork T, Marston DA, Fooks AR, Tryland M, Fuglei E, Muller T (2007) Phylogenetic comparison of rabies viruses from disease outbreaks on the Svalbard Islands. Vector Borne Zoonotic Dis 7:457–460PubMedView Article
  29. Johnson N, Mansfield KL, Hicks D, Nunez A, Healy DM, Brookes SM, Ckimmie C, Fazakerley JK, Fooks AR (2008) Inflammatory responses in the nervous system of mice infected with a street isolate of rabies virus. Dev Biol (Basel) 131:65–72
  30. Kazacos KR, Thacker HL, Shivaprasad HL, Burger PP (1981) Vaccination-induced distemper in kinkajous. J Am Vet Med Assoc 179:1166–1169PubMed
  31. Leblois H, Tuffereau C, Blancou J, Artois M, Aubert A, Flamand A (1990) Oral immunization of foxes with avirulent rabies virus mutants. Vet Microbiol 23:259–266View Article
  32. Macdonald DW (1980) Rabies and wildlife: a biologist’s perspective. Oxford University Press, Oxford
  33. Matouch O, Vitasek J, Semerad Z, Malena M (2007) Rabies-free status of the Czech Republic after 15 years of oral vaccination. Rev Sci Tech Off Int Epizoot 26:577–584
  34. Muller T, Selhorst T, Schuster P, Vos A, Wenzel U, Neubert A (2002) Dynamics of maternal immunity against rabies in fox cubs (Vulpes vulpes). BMC Infect Dis 2:10PubMedView Article
  35. Neubert A, Schuster P, Muller T, Vos A, Pommerening E (2001) Immunogenicity and Efficacy of the Oral Rabies Vaccine SAD B19 in Foxes. J Vet Med B 48:179–183View Article
  36. Wane BM, Wassilak SG, Orenstein WA, Bart KJ, Schonberger LB, Hinman AR, Kew OM (1987) Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. J Am Med Assoc 257:1335–1340View Article
  37. Schneider LG, Barnard BJH, Schneider HP (1985) Application of monoclonal antibodies for epidemiological investigations and oral vaccination studies. III. Oral Rabies Vaccine. In: Kuwert E, Merieux C, Koprowski H, Bogel K (eds) Rabies in the Tropics. Springer, Berlin, pp 47-59
  38. Schneider LG, Cox JH (1983) A field trial for the oral immunization of foxes against rabies in the Federal Republic of Germany. 1. Safety, efficacy and stability of the SAD-B19 vaccine. Tierarztl Umschau 5:315–324
  39. Schuster P, Müller T, Vos A, Selhorst T, Neubert L, Pommerening E (2001) Comparative immunogenicity and efficacy studies with oral rabies virus vaccine SAD P5/88 in raccoon dogs and red foxes. Acta Vet Hung 49:285–290PubMedView Article
  40. Sinnecker H, Apitzsch L, Berndt D, Schrader C, Gogolin J, Egert J (1990) Development of SAD Potsdam 5/88 rabies live vaccination virus for oral immunization of fox—characterization by mouse model. Monatsh Veterinarmed 45:77–78
  41. Smith JS, Yager PA, Baer GM (1973) A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 48:535–541PubMed
  42. Steck F, Wandeler A, Bichsel P, Capt S, Scheider L (1982) Oral immunisation of foxes against rabies. A field study. Zentralbl Veterinarmed B 29:372–396PubMed
  43. Stohr K, Stohr P, Karge E (1992) Isolation of atypical field strains of rabies viruses in Eastern Germany. Tierarztl Umschau 47:820–824
  44. Vos A, Neubert A (2002) Thermo-stability of the oral rabies virus vaccines SAD B19 and SAD P5/88. Dtsch Tierarztl Wochenschr 109:428–432PubMed
  45. Vos A, Neubert A, Aylan O, Schuster P, Pommerening E, Muller T, Chai Chivatsi D (1999) An update on safety studies of SAD B19 rabies virus vaccine in target and non-target species. Epidemiol Infect 123:165–175PubMedView Article
  46. Vos A, Sutor A, Selhorst T, Schwarz S, Potzsch C, Staubach C, Müller T (2004) The spatial and temporal disappearance of different oral rabies vaccine baits. Berl Munch Tierarztl Wochenschr 117:360–366
  47. Wandeler AI (1988) Control of wildlife rabies. In: Campbell JB, Charlton KM (eds) Rabies. Kluwer, Boston, pp 365–380
  48. Webster WA, Casey GA (1996) Virus isolation in neuroblastoma cell culture. In: Meslin FX, Kaplan MM, Koprowski H (eds) Laboratory techniques in rabies, 4th edn. World Health Organization, Geneva, pp 96–104
  49. WHO (1989) Report of WHO Consultation on requirements and criteria for field trials on oral rabies vaccination of dogs and wild carnivores, Geneva, 1–2 March 1989, Doc. WHO/Rab.Res./89.32
  50. WHO expert consultation on rabies, first report (2005) World Health Organisation. WHO Technical Report Series 931:1–87
Metadata
Title
Analysis of vaccine-virus-associated rabies cases in red foxes (Vulpes vulpes) after oral rabies vaccination campaigns in Germany and Austria
Authors
Thomas Müller
H.-J. Bätza
A. Beckert
C. Bunzenthal
J. H. Cox
C. M. Freuling
A. R. Fooks
J. Frost
L. Geue
A. Hoeflechner
D. Marston
A. Neubert
L. Neubert
S. Revilla-Fernández
E. Vanek
A. Vos
E. Wodak
K. Zimmer
T. C. Mettenleiter
Publication date
01-07-2009
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 7/2009
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-009-0408-7

Other articles of this Issue 7/2009

Archives of Virology 7/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.